1. Home
  2. IMNM vs GPRO Comparison

IMNM vs GPRO Comparison

Compare IMNM & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • GPRO
  • Stock Information
  • Founded
  • IMNM 2006
  • GPRO 2004
  • Country
  • IMNM United States
  • GPRO United States
  • Employees
  • IMNM N/A
  • GPRO N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • GPRO Industrial Machinery/Components
  • Sector
  • IMNM Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • IMNM 747.7M
  • GPRO 193.5M
  • IPO Year
  • IMNM 2020
  • GPRO 2014
  • Fundamental
  • Price
  • IMNM $10.97
  • GPRO $1.10
  • Analyst Decision
  • IMNM Strong Buy
  • GPRO Hold
  • Analyst Count
  • IMNM 5
  • GPRO 1
  • Target Price
  • IMNM $28.60
  • GPRO $1.50
  • AVG Volume (30 Days)
  • IMNM 874.7K
  • GPRO 1.6M
  • Earning Date
  • IMNM 11-13-2024
  • GPRO 02-05-2025
  • Dividend Yield
  • IMNM N/A
  • GPRO N/A
  • EPS Growth
  • IMNM N/A
  • GPRO N/A
  • EPS
  • IMNM N/A
  • GPRO N/A
  • Revenue
  • IMNM $10,129,000.00
  • GPRO $896,011,000.00
  • Revenue This Year
  • IMNM N/A
  • GPRO N/A
  • Revenue Next Year
  • IMNM N/A
  • GPRO N/A
  • P/E Ratio
  • IMNM N/A
  • GPRO N/A
  • Revenue Growth
  • IMNM N/A
  • GPRO N/A
  • 52 Week Low
  • IMNM $8.33
  • GPRO $1.08
  • 52 Week High
  • IMNM $30.96
  • GPRO $3.58
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 39.61
  • GPRO 37.45
  • Support Level
  • IMNM $10.76
  • GPRO $1.21
  • Resistance Level
  • IMNM $15.13
  • GPRO $1.36
  • Average True Range (ATR)
  • IMNM 0.98
  • GPRO 0.06
  • MACD
  • IMNM -0.29
  • GPRO -0.01
  • Stochastic Oscillator
  • IMNM 4.81
  • GPRO 9.71

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.

Share on Social Networks: